Researchers genetically reprogrammed mouse nerve cells to reverse cell aging, delaying the onset of ALS symptoms in the animals.| ALS News Today
A repurposed veterinary medication, NUZ-001, helped ALS patients live longer and slowed disease progression in a long-term study.| ALS News Today
A new analysis found Radicava ORS (edaravone) slows functional decline and helps adults with amyotrophic lateral sclerosis (ALS) live longer.| ALS News Today
U.S. and China regulators have now cleared Sineugene Therapeutics' ALS gene therapy SNUG01 for clinical trials.| ALS News Today
Columnist Kristin Neva and her husband, Todd, marked the 15-year anniversary of his ALS diagnosis with a rare outing and outdoor lunch.| ALS News Today
Woolsey received three new U.S. patents covering innovations related to ROCK inhibitor Bravyl (oral fasudil), its investigational ALS drug.| ALS News Today
Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways of diagnosing and treating the disease.| ALS News Today
No description.| ALS News Today
Columnist Dagmar Munn explains how she moved on from a mindset of "why bother?" after her ALS diagnosis. It helps her to live well.| ALS News Today
Two ALS centers launched an initiative to expand access to clinical trials and accelerate improvements in ALS research.| ALS News Today
Category archive page for Columns.| ALS News Today
PrimeC slowed lung function decline and complication-free survival when treatment started early, per data from a Phase 2b ALS clinical trial.| ALS News Today
A brain-computer interface allowed a man with amyotrophic lateral sclerosis to communicate through a computer that used his own voice.| ALS News Today
A Penn State University researcher will use the $250,000 to identify and develop neuroprotective small molecules for ALS and like diseases.| ALS News Today